Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis.

Filippi M, Rocca MA, Calabrese M, Sormani MP, Rinaldi F, Perini P, Comi G, Gallo P.

Neurology. 2010 Nov 30;75(22):1988-94. doi: 10.1212/WNL.0b013e3181ff96f6.

PMID:
21115953
2.

Neuromyelitis optica without typical opticospinal phenotype.

Sato D, Fujihara K.

Mult Scler. 2010 Oct;16(10):1154-5. doi: 10.1177/1352458510377908. No abstract available.

PMID:
20884688
3.

Neuromyelitis optica.

Carroll WM, Fujihara K.

Curr Treat Options Neurol. 2010 May;12(3):244-55. doi: 10.1007/s11940-010-0071-z.

PMID:
20842585
4.

IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum.

Shimizu J, Hatanaka Y, Hasegawa M, Iwata A, Sugimoto I, Date H, Goto J, Shimizu T, Takatsu M, Sakurai Y, Nakase H, Uesaka Y, Hashida H, Hashimoto K, Komiya T, Tsuji S.

Neurology. 2010 Oct 19;75(16):1423-7. doi: 10.1212/WNL.0b013e3181f8832e. Epub 2010 Sep 8.

PMID:
20826711
5.

Magnetic resonance imaging features of the spinal cord in pediatric multiple sclerosis: a preliminary study.

Verhey LH, Branson HM, Makhija M, Shroff M, Banwell B.

Neuroradiology. 2010 Dec;52(12):1153-62. doi: 10.1007/s00234-010-0755-9. Epub 2010 Aug 19.

PMID:
20721543
6.

Brain macro- and microscopic damage in patients with paediatric MS.

Absinta M, Rocca MA, Moiola L, Ghezzi A, Milani N, Veggiotti P, Comi G, Filippi M.

J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1357-62. doi: 10.1136/jnnp.2010.205682. Epub 2010 Jul 26.

PMID:
20660915
7.

Compliance with McDonald criteria and red flag recognition in a general neurology practice in Ireland.

Albertyn C, O'Dowd S, McHugh J, Murphy R.

Mult Scler. 2010 Jun;16(6):678-84. doi: 10.1177/1352458510368688.

PMID:
20558501
8.

The radiologically isolated syndrome: take action when the unexpected is uncovered?

Sellner J, Schirmer L, Hemmer B, Mühlau M.

J Neurol. 2010 Oct;257(10):1602-11. doi: 10.1007/s00415-010-5601-9. Epub 2010 May 26. Review.

PMID:
20503053
9.

A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.

Calabrese M, Rocca MA, Atzori M, Mattisi I, Favaretto A, Perini P, Gallo P, Filippi M.

Ann Neurol. 2010 Mar;67(3):376-83. doi: 10.1002/ana.21906.

PMID:
20373349
10.

A comparison of MRI criteria for diagnosing pediatric ADEM and MS.

Ketelslegers IA, Neuteboom RF, Boon M, Catsman-Berrevoets CE, Hintzen RQ; Dutch Pediatric MS Study Group.

Neurology. 2010 May 4;74(18):1412-5. doi: 10.1212/WNL.0b013e3181dc138b. Epub 2010 Mar 24.

PMID:
20335562
11.

Pediatric multiple sclerosis.

Venkateswaran S, Banwell B.

Neurologist. 2010 Mar;16(2):92-105. doi: 10.1097/NRL.0b013e3181c923d5. Review.

PMID:
20220443
12.

Multiple sclerosis: can retinal imaging accurately detect optic neuritis?

Frohman EM, Balcer LJ, Calabresi PA.

Nat Rev Neurol. 2010 Mar;6(3):125-6. doi: 10.1038/nrneurol.2010.13. No abstract available.

PMID:
20212426
13.

The McDonald Criteria for Multiple Sclerosis: time for clarification.

Hawkes CH, Giovannoni G.

Mult Scler. 2010 May;16(5):566-75. doi: 10.1177/1352458510362441. Epub 2010 Mar 1.

PMID:
20194583
14.

MRI criteria for MS in patients with clinically isolated syndromes.

Montalban X, Tintoré M, Swanton J, Barkhof F, Fazekas F, Filippi M, Frederiksen J, Kappos L, Palace J, Polman C, Rovaris M, de Stefano N, Thompson A, Yousry T, Rovira A, Miller DH.

Neurology. 2010 Feb 2;74(5):427-34. doi: 10.1212/WNL.0b013e3181cec45c. Epub 2010 Jan 6.

PMID:
20054006
15.

Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.

Montalban X, Sastre-Garriga J, Filippi M, Khaleeli Z, Téllez N, Vellinga MM, Tur C, Brochet B, Barkhof F, Rovaris M, Miller DH, Polman CH, Rovira A, Thompson AJ.

Mult Scler. 2009 Dec;15(12):1459-65. doi: 10.1177/1352458509348422. Epub 2009 Dec 7.

PMID:
19995843
16.

Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis.

Yeh EA, Weinstock-Guttman B, Ramanathan M, Ramasamy DP, Willis L, Cox JL, Zivadinov R.

Brain. 2009 Dec;132(Pt 12):3392-400. doi: 10.1093/brain/awp278.

PMID:
19892770
17.

Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases.

Brettschneider J, Jaskowski TD, Tumani H, Abdul S, Husebye D, Seraj H, Hill HR, Fire E, Spector L, Yarden J, Dotan N, Rose JW.

J Neuroimmunol. 2009 Dec 10;217(1-2):95-101. doi: 10.1016/j.jneuroim.2009.07.017. Epub 2009 Oct 30.

PMID:
19879655
18.

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.

Hawker K, O'Connor P, Freedman MS, Calabresi PA, Antel J, Simon J, Hauser S, Waubant E, Vollmer T, Panitch H, Zhang J, Chin P, Smith CH; OLYMPUS trial group.

Ann Neurol. 2009 Oct;66(4):460-71. doi: 10.1002/ana.21867.

PMID:
19847908
19.

Pediatric multiple sclerosis.

Yeh EA, Chitnis T, Krupp L, Ness J, Chabas D, Kuntz N, Waubant E; US Network of Pediatric Multiple Sclerosis Centers of Excellence.

Nat Rev Neurol. 2009 Nov;5(11):621-31. doi: 10.1038/nrneurol.2009.158. Epub 2009 Oct 13. Review.

PMID:
19826402
20.

Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls.

Keller A, Leidinger P, Lange J, Borries A, Schroers H, Scheffler M, Lenhof HP, Ruprecht K, Meese E.

PLoS One. 2009 Oct 13;4(10):e7440. doi: 10.1371/journal.pone.0007440.

Supplemental Content

Support Center